Currently, therapeutic options for AD remain limited, primarily consisting of acetylcholinesterase inhibitors, anti-inflammatory agents such as curcumin, ellagic acid, and galantamine, as well as interventions aimed at reducing Aβ deposition and tau phosphorylation, including electroacupuncture, isoastilbin, and plant polyphenols. Here, MAPT is linked to Alzheimer disease.